已收盘 12-19 16:00:00 美东时间
-0.074
-21.58%
(来源:数智猿) 该项目案例由商汤科技投递并参与数智猿×数据猿×上海大数据联盟共同推出的#技术向善·榜样的力量#《2025中国数智产业最具社会责任感企业...
09-01 20:46
北京时间2024年09月28日03时15分,万春医药(BYSI.us)股票出现波动,股价急速上涨6.83%。截至发稿,该股报2.19美元/股,成交量2.2928万股,换手率0.06%,振幅6.34%。 最近的财报数据显示,该股实现营业收入1000000.00美元,净利润-7.26百万美元,每股收益-0.19美元,毛利--,市盈率-5.25倍。 机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。 万春医药股票所在的生物技术行业中,整体跌幅为1.10%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Onconetix...
2024-09-28 03:15
Gainers Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock increased by 16.8% to $0....
2024-09-27 04:31
Stifel analyst Stephen Willey maintains Cue Biopharma (NASDAQ:CUE) with a Buy and lowers the price target from $8 to $4.
2024-08-20 19:36
05:23 PM EDT, 08/19/2024 (MT Newswires) -- Cue Biopharma (CUE) reported a Q2 net loss late Monday of $0.20 per diluted share, narrowing from a loss of $0.29 a year earlier. Four analysts polled by Capital IQ expected a loss of $0.27. Revenue for the quarter ended June 30 was $2.7 million, up from $1...
2024-08-20 05:23
Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.24) by 16.67 percent. The company reported quarterly sales of $2.658 million which beat the analyst consensus estimate of $1.293 million by 105.61 percent. This is a 92.33 perce...
2024-08-20 04:12